MYCO Capsules |
120 capsules (650 mg each)
This product is no longer sold by Raintree Nutrition, Inc. See the main product page for more information why. Try doing a google search or see the rainforest products page to find other companies selling rainforest herbal supplements or rainforest plants if you want to make this rainforest formula yourself.
A synergistic formula of 8 rainforest botanicals independently documented with anti-mycoplasmal actions* Recent research has reported that many autoimmune diseases may have an underlying infection by a mycoplasma bacteria.* This product was featured in an article by the Health Sciences Institute. Some people find this article helpful as well.
For more information on the individual ingredients in the Myco formula, follow the links provided below to the plant database files in the Tropical Plant Database. More information can also be found in the new Antimicrobial Guide.
Ingredients: A proprietary blend of mullaca, Brazilian peppertree, anamu, clavillia, macela, fedegoso, pic„o preto, and uva ursi. To prepare this natural remedy yourself: use two parts each mullaca, Brazilian peppertree and anamu and one part each of the remaining plants in the list. To make a small amount... "1 part" could be one tablespoon (you'd have 11 tablespoons of the blended herbal formula). For larger amounts, use "1 part" as one ounce or one cup or one pound. Combine all the herbs together well. The herbal mixture can then be stuffed into capsules or brewed into tea, stirred into juice or other liquid, or taken however you'd like.
Suggested Use: Take 2 grams twice daily. (One gram is approximately 1/2 teaspoon)
Contraindications: None reported.
Drug Interactions: None reported.
Other Practitioner Observations:
- Several plants in this formula have been documented to reduce blood pressure in animal studies. Individuals with low blood pressure should be monitored for this possible effect.
- All of the plants in this formula have demonstrated antimicrobial (antimycoplasmal, antibacterial, & antimycobacterial) effects in laboratory studies. Supplementing the diet with probiotics and digestive enzymes is advisable when this formula is used for longer than 30 days.
Third-Party Published Research*
This rainforest formula has not been the subject of any clinical research. A partial listing of the published research on each herbal ingredient in the formula is shown below. Please refer to the plant database files by clicking on the plant names below to see all available documentation and research.
Mullaca (Physalis angulata)
Mullaca has demonstrated broad-spectrum antibacterial and antimycobacterial actions in laboratory tests against Corynebacterium diphtheriae, Klebsiella, Neisseria, Pseudomonas, Staphylococcus, Strepto-coccus, Bacillus, Tubercule bacillus; as well as, Mycobacterium intracellulare, M. malmoense, M. avium, M. kansasi, and M. tuberculosis.*
Osho, A., et al. "Antimicrobial activity of essential oils of Physalis angulata. L." Afr J Tradit Complement Altern Med. 2010;7(4):303-6.
Silva, M. T., et al. “Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.” Mem. Inst. Oswaldo Cruz. 2005 Nov; 100(7): 779-82.
Hwang, J. K., et al. “Anticariogenic activity of some tropical medicinal plants against Streptococcus mutans.” Fitoterapia. 2004 Sep; 75(6): 596-8.
Pietro, R. C., et al. “In vitro antimycobacterial activities of Physalis angulata L.” Phytomedicine 2000; 7(4): 335–38.
Januario, A. H., et al. “Antimycobacterial physalins from Physalis angulata L. (Solanaceae).” Phytother. Res. 2002; 16(5): 445-48.
Hussain, H., et al. “Plants in Kano ethnomedicine; screening for antimicrobial activity and alkaloids.” Int. J. Pharmacol. 1991; 29(1): 51–56.
Otake, T., et al. “Screening of Indonesian plant extracts for anti-Human Immunodeficiency Virus-Type 1 (HIV-1) Activity.” Phytother. Res. 1995; 9(1): 6–10.
Kurokawa, M., et al. “Antiviral traditional medicines against Herpes simplex virus (HSV-1), polio virus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice." Antiviral Res. 1993; 22(2/3): 175–88.
Kusumoto, I. T., et al. “Screening of some Indonesian medicinal plants for inhibitory effects on HIV-1 protease.” Shoyakugaku Zasshi 1992; 46(2): 190-93.
Ogunlana, E. O., et al. “Investigations into the antibacterial activities of local plants.” Planta Med. 1975; 27: 354.
Brazilian peppertree (Schinus molle)
Brazilian peppertree has demonstrated very strong antibacterial actions against numerous bacteria and 2 patents using this plant's essential oil have been awarded for a topical bactericidal medicine used against Pseudomonas and Staphylococcus for humans and animals, and as an ear, nose, and/or throat preparation against bacteria.*
Gomes, F., et al. "Antimicrobial lectin from Schinus terebinthifolius leaf." J Appl Microbiol. 2012 Nov 28.
Rocha, P., et al. "Synergistic Antibacterial Activity of the Essential Oil of Aguaribay (Schinus molle L.)." Molecules. 2012 Oct 12;17(10):12023-36.
Montanari, R., et al. "Exposure to Anacardiaceae volatile oils and their constituents induces lipid peroxidation within food-borne bacteria cells." Molecules. 2012 Aug 14;17(8):9728-40
Moura-Costa, G., et al. "Antimicrobial activity of plants used as medicinals on an indigenous reserve in Rio das Cobras, ParanŠ, Brazil." J Ethnopharmacol. 2012 Sep 28;143(2):631-8.
Leite, S., et al. "Randomized clinical trial comparing the efficacy of the vaginal use of metronidazole with a Brazilian pepper tree (Schinus) extract for the treatment of bacterial vaginosis." Braz J Med Biol Res. 2011 Mar;44(3):245-52
Johann, S., et al. "Antifungal activity of schinol and a new biphenyl compound isolated from Schinus terebinthifolius against the pathogenic fungus Paracoccidioides brasiliensis." Ann Clin Microbiol Antimicrob. 2010 Oct 12;9:30.
Pereira, E., et al. "In vitro antimicrobial activity of Brazilian medicinal plant extracts against pathogenic microorganisms of interest to dentistry." Planta Med. 2011 Mar;77(4):401-4.
Johann, S., et al. "Antifungal activity of extracts of some plants used in Brazilian traditional medicine against the pathogenic fungus Paracoccidioides brasiliensis." Pharm Biol. 2010 Apr;48(4):388-96.
Johann, S., et al. "Antifungal activity of schinol and a new biphenyl compound isolated from Schinus terebinthifolius against the pathogenic fungus Paracoccidioides brasiliensis" Ann Clin Microbiol Antimicrob. 2010; 9: 30.
Salazar-Aranda, R., et al. "Antimicrobial and Antioxidant Activities of Plants from Northeast of Mexico"
Evid Based Complement Alternat Med. 2011; 2011: 536139.
Salazar-Aranda, R., et al. "Antimicrobial and Antioxidant Activities of Plants from Northeast of Mexico." Evid. Based Complement. Alternat. Med. 2009 Sep 21.
El-Massry, K., et al. "Chemical compositions and antioxidant/antimicrobial activities of various samples prepared from Schinus terebinthifolius leaves cultivated in Egypt." J. Agric. Food Chem. 2009 Jun; 57(12): 5265-70.
Hayouni el, A., et al. "Tunisian Salvia officinalis L. and Schinus molle L. essential oils: their chemical compositions and their preservative effects against Salmonella inoculated in minced beef meat." Int. J. Food Microbiol. 2008 Jul; 125(3): 242-51.
Molina-Salinas, G., et al. "Evaluation of the flora of Northern Mexico for in vitro antimicrobial and antituberculosis activity." J. Ethnopharmacol. 2006 Aug 23;
de Lima, M. R., et al. “Anti-bacterial activity of some Brazilian medicinal plants.” J. Ethnopharmacol. 2006 Apr; 105(1-2): 137-47.
Schmourlo, G., et al. “Screening of antifungal agents using ethanol precipitation and bioautography of medicinal and food plants.” J. Ethnopharmacol. 2005 Jan; 96(3): 563-8.
de Carvalho, M. C. “Evaluation of mutagenic activity in an extract of pepper tree stem bark (Schinus terebinthifolius Raddi).”
Environ. Mol. Mutagen. 2003; 42(3): 185-91.
de Melo, Jr., E. J., et al. “Medicinal plants in the healing of dry socket in rats: Microbiological and microscopic analysis.” Phytomedicine. 2002; 9(2): 109–16.
Quiroga, E. N., et al. “Screening antifungal activities of selected medicinal plants.” J. Ethnopharmacol. 2001; 74(1): 89–96.
Camano, R. “Essential oil composition with bactericide activity.” United States patent 5,635,184; June 3, 1997.
Camano, R. “Method for treating bacterial infections.” United States patent 5,512,284; April 30, 1996.
Martinez, M. J., et al. “Screening of some Cuban medicinal plants for antimicrobial activity.” J. Ethnopharmacol. 1996; 52(3): 171–74.
Cuella, M. J., et al. “Two fungal lanostane derivatives as phospholipase A2 inhibitors.” J. Nat. Prod. 1996; 59(10): 977–79.
Gundidza, M., et al. “Antimicrobial activity of essential oil from Schinus molle Linn.” Central African J. Med. 1993; 39(11): 231–34.
Dikshit, A. “Schinus molle: a new source of natural fungitoxicant.” Appl. Environ. Microbiol. 1986; 51(5): 1085–88.
El-Keltawi, N., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Herba Pol. 1980; 26(4): 245–50.
Ross, S., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Fitoterapia. 1980; 51: 201–5.
Simons, J., et al. “Succulent-type as sources of plant virus inhibitors.” Phytopathology. 1963; 53: 677–83.
Anamu (Petiveria alliacea)
Anamu has demonstrated antimicrobial properties in vitro against numerous pathogens, including Escherichia coli, Staphylococcus, Pseudomonas, Shigella, Mycobacterium tuberculosis, several strains of fungi, and Candida.* Researchers from Guatemala and Austria confirmed anamu's activity in in vitro and in vivo studies against several strains of protozoa, bacteria, and fungi.*
Kim, S., et al. “Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L.” J. Ethnopharmacol. 2006 Mar; 104(1-2): 188-92.
Kubec, R., et al. “The lachrymatory principle of Petiveria alliacea.” Phytochemistry. 2003 May; 63(1): 37-40.
Ruffa, M. J., et al. “Antiviral activity of Petiveria alliacea against the bovine diarrhea virus. Chemotherapy 2002; 48(3): 144-47.
Benevides, P. J., et al. “Antifungal polysulphides from Petiveria alliacea L.” Phytochemistry. 2001; 57(5): 743-7.
Caceres, A., et al. “Plants used in Guatemala for the treatment of protozoal infections. I. Screening of activity to bacteria, fungi and American trypanosomes of 13 native plants.” J. Ethnopharmacol. 1998 Oct; 62(3): 195-202.
Berger, I., et al. “Plants used in Guatemala for the treatment of protozoal infections: II. Activity of extracts and fractions of five Guatemalan plants against Trypanosoma cruzi.” J. Ethnopharmacol. 1998 Sep; 62(2): 107-15.
Hoyos, L., et al. “Evaluation of the genotoxic effects of a folk medicine, Petiveria alliaceae (Anamu).” Mutat. Res. 1992; 280(1): 29-34.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatophytic infections. I. Screening for antimycotic activity of 44 plant extracts.” J. Ethnopharmacol. 1991; 31(3): 263-76.
Misas, C.A.J., et al. “The biological assessment of Cuban plants. III.” Rev. Cub. Med. Trop. 1979; 31(1): 21–27.
Von Szczepanski, C., et al. “Isolation, structure elucidation and synthesis of an antimicrobial substance from Petiveria alliacea.” Arzneim-Forsch 1972; 22: 1975–.
Feng, P., et al. “Further pharmacological screening of some West Indian medicinal plants.” J. Pharm. Pharmacol. 1964; 16: 115.
Santander, S., et al. "Immunomodulatory effects of aqueous and organic fractions from Petiveria alliacea on human dendritic cells." Am J Chin Med. 2012;40(4):833-44
Williams, L. "Life's immunity as a normal distribution function: philosophies for the use of dibenzyl trisulphide in immunity enhancement and life extension." West Indian Med J. 2010 Oct;59(5):455.
Queiroz, M. L., et al. “Cytokine profile and natural killer cell activity in Listeria monocytogenes infected mice treated orally with Petiveria alliacea extract. Immunopharmacol. Immunotoxicol. 2000 Aug; 22(3): 501-18.
Quadros, M. R., et al. “Petiveria alliacea L. extract protects mice against Listeria monocytogenes infection—effects on bone marrow progenitor cells.” Immunopharmacol. Immunotoxicol. 1999 Feb; 21(1): 109-24.
Williams, L., et al. “Immunomodulatory activities of Petiveria alliaceae L.” Phytother. Res. 1997; 11(3): 251253.
Rossi, V., “Effects of Petiveria alliacea L. on cell immunity.” Pharmacol. Res. 1993; 27(1): 111-12.
Marini, S., “Effects of Petiveria alliacea L. on cytokine production and natural killer cell activity.” Pharmacol. Res. 1993; 27(1): 107-08.
Clavillia (Mirabilis jalapa)
Clavillia contains patented mirabilis antiviral proteins (MAPs) which have shown specific antiviral, antibacterial, and antifungal actions in laboratory research.*
Michalet, S., "N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors." Bioorg. Med. Chem. Lett. 2007 Mar; 17(6): 1755-8.
Bolognesi, A. et al. “Ribosome-inactivating and adenine polynucleotide glycosylase activities in Mirabilis jalapa L. tissues.” J. Biol. Chem. 2002; 277(16) 13709–16.
Yang, S. W., et al. “Three new phenolic compounds from a manipulated plant cell culture, Mirabilis jalapa.” J. Nat. Prod. 2001; 64(3): 313–17.
Vivanco, J. M., et al. “Characterization of two novel type 1 ribosome-inactivating proteins from the storage roots of the Andean crop Mirabilis expansa.” Plant Physiol. 1999; 119(4): 1447–56.
Dimayuga, R. E., et al. ”Antimicrobial activity of medicinal plants from Baja California Sur (Mexico).” Pharmaceutical Biol. 1998; 36(1): 33–43.
De Bolle, M. F., et al. “Antimicrobial peptides from Mirabilis jalapa and Amarantus caudatus: expression, processing, localization and biological activity in transgenic tobacco.” Plant Mol. Biol. 1996; 31(5): 993–1008.
Kataoka, J., et al. “Adenine depurination and inactivation of plant ribosomes by an antiviral protein of Mirabilis jalapa (MAP).” Plant Mol. Biol. 1992; 20(6): 111–19.
Wong, R. N., et al. “Characterization of Mirabilis antiviral protein—a ribosome inactivating protein from Mirabilis jalapa L.” Biochem. Int. 1992; 28(4): 585–93.
Cammue, B. P., et al. “Isolation and characterization of a novel class of plant antimicrobial peptides from Mirabilis jalapa L. seeds.” J. Biol. Chem. 1992; 267(4): 2228–33.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatophytic infections. Screening for antimycotic activity of 44 plant extracts.” J. Ethnophamacol. 1991; 31(3): 263–76.
Kusamba, C., et al. “Antibacterial activity of Mirabilis jalapa seed powder.” J. Ethnopharmacol. 1991; 35(2): 197–99.
Caceres, A., et al. “Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases.” J. Ethnopharmacol. 1987; 20(3): 223–37.
Macela (Achyrocline satureoides)
Macela has demonstrated in laboratory studies antiviral, antibacterial, antimycoplasmal, and immuno-stimulant actions.*
Casero, C., et al. "Achyrofuran is an antibacterial agent capable of killing methicillin-resistant vancomycin-intermediate Staphylococcus aureus in the nanomolar range." Phytomedicine. 2012 Dec 4. doi:pii: S0944-7113(12)00406-0.
Joray, M., et al. "Understanding the interactions between metabolites isolated from Achyrocline satureioides in relation to its antibacterial activity." Phytomedicine. 2012 Nov 30. doi:pii: S0944-7113(12)00381-9
Joray, M., et al. "Antibacterial activity of extracts from plants of central Argentina--isolation of an active principle from Achyrocline satureioides." Planta Med. 2011 Jan;77(1):95-100.
Sabini, M., et al. "Evaluation of antiviral activity of aqueous extracts from Achyrocline satureioides against Western equine encephalitis virus." Nat Prod Res. 2012;26(5):405-15.
Gonzales, M., et al. "Antibacterial activity of water extracts and essential oils of various aromatic plants against Paenibacillus larvae, the causative agent of American Foulbrood." J Invertebr Pathol. 2010 Jul;104(3):209-13.
Vogt, V., et al. "Fungitoxic effects of Achyrocline satureioides (marcela) on plant pathogens." IDECEFYN
vol 21 January-April 2010, 109-112
Bueno-SŠnchez J., et al. "Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia."
Biomedica. 2009 Mar;29(1):51-60.
Brandelli, C., et al. "Indigenous traditional medicine: in vitro anti-giardial activity of plants used in the treatment of diarrhea." Parasitol Res. 2009 Jun;104(6):1345-9.
Calvo, D., et al. "Achyrocline satureioides (LAM.) DC (Marcela): antimicrobial activity on Staphylococcus spp. and immunomodulating effects on human lymphocytes." Rev Latinoam Microbiol. 2006 Jul-Dec;48(3-4):247-55.
Bettega, J. M., et al. “Evaluation of the antiherpetic activity of standardized extracts of Achyrocline
satureioides.” Phytother. Res. 2004; 18(10): 819-23.
Zanon, S. M., et al. “Search for antiviral activity of certain medicinal plants from Cordoba, Argentina.” Rev. Latinoamer. Microbiol. 1999; 41(2): 59–62.
Abdel-Malek, S., et al. “Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity.” J. Ethnopharmacol. 1996; 50: 157–22.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol. 1993; 39(2): 119–28.
Vargas, V., et al. “Genotoxicity of plant extracts.” Mem. Inst. Oswaldo Cruz 1991; 86(11): 67–70.
Vargas, V., et al. “Mutagenic and genotoxic effects of aqueous extracts of Achyrocline satureoides in
prokaryotic organisms.” Mutat. Res. 1990; 240(1): 13–18.
de Souza, C. P., et al. “Chemoprophylaxis of schistosomiasis: molluscicidal activity of natural products.” An. Acad. Brasil. Cienc. 1984; 56(3): 333–38.
Fedegoso (Cassia occidentalis)
Fedegoso has demonstrated antibacterial actions against E. coli, Salmonella, Bacillus, Pseudomonas, and Staphylococcus in laboratory tests and antiviral actions against acute hepatitis in one human study.*
Bhagat, M., et al. "Evaluation of Cassia occidentalis for in vitro cytotoxicity against human cancer cell lines and antibacterial activity." Indian J Pharmacol. 2010 Aug;42(4):234-7.
Li, S., et al. "Cycloartane triterpenoids from Cassia occidentalis." Planta Med. 2012 May;78(8):821-7.
Evans CE, et al. “Efficacy of some nupe medicinal plants against Salmonella typhi: an in vitro study.” J. Ethnopharmacol. 2002 Apr; 80(1): 21-4.
Samy, R. P., et al. “Antibacterial activity of some folklore medicinal plants used by tribals in Western Ghats of India.” J. Ethnopharmacol. 2000; 69(1): 63–71.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol. 1993; 39(2): 119–28.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatophytic infections. 1. Screening for antimycotic activity of 44 plant extracts.” J. Ethnopharmacol. 1991; 31(3): 263–76.
Hussain, H., et al. “Plants in Kano ethomedicine: screening for antimicrobial activity and alkaloids.” Int. J. Pharmacog. 1991; 29(1): 51–6.
Gaind, K. N., et al. “Antibiotic activity of Cassia occidentalis.” Indian J. Pharmacy 1966; 28(9): 248–50.
Bin-Hafeez, B., et al. “Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice.” J. Ethnopharmacol. 2001; 75(1): 13–18.
Picão Preto (Bidens pilosa)
Pic„o preto's antimicrobial activity against Klebsiella pneumonia, Bacillus, Neisseria gonorrhea, Pseudo-monas, Staphylococcus, and Salmonella have been reported through in vitro testing.* It was also reported to have antimycobacterial activity towards Mycobacterium tuberculosis and M. smegmatis.*
Nakama, S., et al. "Efficacy of Bidens pilosa Extract against Herpes Simplex Virus Infection In Vitro and In Vivo." Evid Based Complement Alternat Med. 2012;2012:413453.
Adedapo, A., et al. "Comparison of the nutritive value and biological activities of the acetone, methanol and water extracts of the leaves of Bidens pilosa and Chenopodium album." Acta Pol Pharm. 2011 Jan-Feb;68(1):83-92.
Tobinaga, S., et al. "Isolation and identification of a potent antimalarial and antibacterial polyacetylene from Bidens pilosa." Planta Med. 2009 May;75(6):624-8.
Rojas, J. J., et al. "Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: A possible alternative in the treatment of non-nosocomial infections." BMC Complement. Altern. Med. 2006 Feb; 6(1): 2.
Chang, S., et al. "Flavonoids, centaurein and centaureidin, from Bidens pilosa, stimulate IFN-gamma expression."
J Ethnopharmacol. 2007 Jun 13;112(2):232-6.
Chiang, Y., et al. "Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator." J Ethnopharmacol. 2007 Apr 4;110(3):532-8.
Chiang, Y. M., et al. "Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator." J. Ethnopharmacol. 2006 Oct 19;
Abajo, C., et al. “In vitro study of the antioxidant and immunomodulatory activity of aqueous infusion of Bidens pilosa.” J. Ethnopharmacol. 2004 Aug; 93(2-3): 319-23.
Chang, S. L., et al. “Polyacetylenic compounds and butanol fraction from Bidens pilosa can modulate the differentiation of helper T cells and prevent autoimmune diabetes in non-obese diabetic mice.” Planta Med. 2004; 70(11):1045-51.
Khan, M. R., et al. “Anti-microbial activity of Bidens pilosa, Bischofia javanica, Elmerillia papuana and Sigesbekia orientalis.” Fitoterapia. 2001; 72(6): 662–65.
Chariandy, C. M., et al. “Screening of medicinal plants from Trinidad and Tobago for antimicrobial and insecticidal properties.” J. Ethnopharmacol. 1999; 64(3): 265–70.
Rabe, T. “Antibacterial activity of South African plants used for medicinal purposes.” J. Ethnopharmacol. 1997; 56(1): 81–7.
van Puyvelde, L., et al. “In vitro inhibition of mycobacteria by Rwandese medicinal plants.” Phytother. Res. 1994; 8(2): 65–9.
Desta, B. “Ethiopian traditional herbal drugs. Part II: Antimicrobial activity of 63 medicinal plants.” J. Ethnopharmacol. 1993; 39(2): 129–39.
Sarg, T. M., et al. “Constituents and biological activity of Bidens pilosa l grown in Egypt.” Acta. Pharm. Hung. 1991; 61(6): 317–23.
Geissberger, P., et al. “Constituents of Bidens pilosa L.: do the components found so far explain the use of this plant in traditional medicine?” Acta Trop. 1991; 48(4): 251–61.
Hudson, J. B., et al. “Investigation of the antiviral action of the photoactive compound phenylheptatriyne.” Photochem. Photobiol. 1986; 43(1): 27–33.
Boily, Y., et al. “Screening of medicinal plants of Rwanda (central Africa) for antimicrobial activity.” J. Ethnopharmacol. 1986; 16(1): 1–13.
Bondarenko, A. S., et al. “The antimicrobial properties of the polyacetylene antibiotic phenylheptatriyne.” Mikrobiol. Zh. 1985; 47(2): 81–3.
Hudson, J. B., et al. “Nature of the interaction between the photoactive compound phenylheptatriyne and animal viruses.” Photochem. Photobiol. 1982; 36(2): 181–85.
Arnason, T., et al. “Photosensitization of Escherichia coli and Saccharomyces cerevisiae by phenylheptatriyne from Bidens pilosa.” Can. J. Microbiol. 1980; 26(6): 698–705.
Uva Ursi (Arctostaphylos uva-ursi)
Uva ursi has been documented in laboratory research with antimycoplasmal actions against Ureaplasma urealyticum and Mycoplasma hominis.*
Cybulska, P., et al. "Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles." Sex Transm Dis. 2011 Jul;38(7):667-71.
Kruszewska, H., et al. “Examination of antimicrobial activity of selected non-antibiotic drugs.” Acta Pol. Pharm. 2004 Dec; 61 Suppl: 18-21.
Jahodar, L., et al. “Antimicrobial effect of arbutin and an extract of the leaves of Arctostaphylos uva-ursi in vitro.” Cesk Farm. 1985; 34(5):174-8.
Robertson, J. A., et al. “Effect of carbohydrates on growth of Ureaplasma urealyticum and Mycoplasma hominis.” J. Clin. Microbiol. 1987; 25(1): 160-1.
Newton, M., et al. “Select herbal remedies used to treat common urologic conditions.” Urol Nurs. 2001 Jun; 21(3): 232-4.
Floresne, V., et al. “Microbiological testing of uva ursi species (Formulaes Normales V)” Acta Pharm. Hung. 1984 Jul; 54(4): 170-5.
*The statements contained herein have not been evaluated
by the Food and Drug Administration. The information contained herein is intended and provided for education, research, entertainment and information purposes only. This information is not intended to be used to diagnose, prescribe or replace proper medical care. The plants and/or formulas described herein are not intended to treat, cure, diagnose, mitigate or prevent any disease and no medical claims are made.
Please refer to our Conditions of Use for this web site.
© Copyrighted 1996
to present by Leslie Taylor, Milam County, TX 77857.
All rights reserved. Please read the Conditions of Use, and Copyright Statement
for this web page and web site.
Last updated 12-31-2012